CD46 and neoplasm: Indeed, the B16-CD46 model was resistant to checkpoint inhibitor monotherapy, whereas mLOAd703 alone could hamper tumor growth and induce an immune response as shown by increased immune cell infiltration in the tumor and elevated cytokine and chemokine levels in the serum.